ARM Holdings plc Has Lost Its Reach, But Here’s An Ideagen PLC For You…

If you’re not enamoured with ARM Holdings plc (LON:ARM) then one Fool suggests taking a look at Ideagen plc (LON:IDEA).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last year I told Fools that ARM Holdings (LSE: ARM) (NASDAQ: ARMH.US) was a company exiting a decade-long run of higher-than-normal growth. Since then, the company has increased in value by around 11%, which might make some tempted to jump in on the back of what appear to be nice returns.

But not so fast. For while the price of ARM has extended in the last three-month period, so has the stock’s beta (the calculation of its overall price volatility). Beta measures the risk of holding a stock during the period in which returns are being calculated: the higher the beta, the lower the risk-adjusted return.

In the case of ARM, the stock plunged almost 13% in value to a 52-week low over the period before it resurfaced, creating a higher beta value. Thus accounting for ARM’s beta therefore produces a risk-adjusted return of barely 3% or so over the previous three-month period. That no longer looks like such impressive growth. So what does right now?

A New Idea For A New Year

As growth investors, what we want are stocks where growth is consistently being managed – not the stuff that is tarnished by wild interim high-low swings. This is especially important if you like to shuffle money between different holdings as various investment opportunities appear on the horizon.

Of course, technology is a great place to find this sort of growth, as its effect is to streamline costs while producing exponential income. Combine these two forces and you have something resembling constant value creation in a portfolio.

For a company harnessing these kinds of attributes via an interesting strategy revolving around acquisitions, look no further than Ideagen (LSE: IDEA).

Since mid-December, Ideagen has risen in value by a fifth, compounding a year-long 17% climb. (Contrast this to ARM’s recent rally, which merely shortened a 52-week 9% decline overall.)

Ideagen’s intrinsic market capitalisation jumped to £63.5m in December when the company raised £17m for an acquisition it picked up after a new stock issuance that was oversubscribed by a whopping £40m, including 11 new institutional shareholders. The company still trades well below this valuation, making it appear like great value.

Why all the fervour in the City for Ideagen’s shares? Because the company uses tech in tandem with strong management to both increase the earnings and decrease the costs of the acquisition target, creating constantly exponential P/E growth. That in turn means a share price that keeps rising with an impressive risk-adjusted return attached.

Ideagen’s strategy is to make an acquisition, then centralise costs of the target to cut back 10% of overhead while creating cross-selling synergies to drive revenue growth an additional 10%.

Is It A Bird, Is It A Plane …. No, It’s A Superstock 

Ideagen’s acquisition at the end of 2014 of software developer Gael is a classic example of how the company creates value. For a start, Ideagen picked the maker of risk and compliance software – which supplies the life sciences, aviation, healthcare and manufacturing industries – up for a song, at 7.8 times EBITDA.

The acquisition, when spread out across the company’s existing sales channels, is immediately earnings-enhancing. Gael will add £9 million in revenues and EBITDA of £2.3 million to Ideagen’s 2014 earnings, and those earnings are expected to grow at an exciting 24% clip throughout 2015.

In addition, Ideagen picked up 1,000 new customers in the tricky compliance and standards management sector, including various NHS units and complex manufacturing clients.

That’s a value-creation story you’d be crazy not to take part in.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Daniel Mark Harrison has no position in any shares mentioned. The Motley Fool UK has recommended ARM Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »